Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy.
Ann Hepatol. 2021 Dec;26:100540. doi: 10.1016/j.aohep.2021.100540. Epub 2021 Sep 25.
Ann Hepatol. 2021.
PMID: 34583061
Free article.
Novel therapies in hepatitis B and C.
Takkenberg B, de Bruijne J, Weegink C, Jansen P, Reesink H.
Takkenberg B, et al.
Curr Gastroenterol Rep. 2008 Feb;10(1):81-90. doi: 10.1007/s11894-008-0013-z.
Curr Gastroenterol Rep. 2008.
PMID: 18417047
Review.
Item in Clipboard
Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B, Terpstra V, Zaaijer H, Weegink C, Dijkgraaf M, Jansen P, Beld M, Reesink H.
Takkenberg B, et al.
J Gastroenterol Hepatol. 2011 Oct;26(10):1527-35. doi: 10.1111/j.1440-1746.2011.06766.x.
J Gastroenterol Hepatol. 2011.
PMID: 21557773
Clinical Trial.
Item in Clipboard
Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
de Niet A, Jansen L, Zaaijer HL, Klause U, Takkenberg B, Janssen HL, Chu T, Petric R, Reesink HW.
de Niet A, et al.
Antivir Ther. 2014;19(3):259-67. doi: 10.3851/IMP2707. Epub 2013 Nov 21.
Antivir Ther. 2014.
PMID: 24256626
Clinical Trial.
Item in Clipboard
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Wieske L, Stalman EW, van Dam PJK, Kummer LY, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink G, Van der Kooi A, Raaphorst J, Löwenberg M, Takkenberg B, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl A, Broens B, Parra Sanchez A, van Els CACM, Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, Van der Pol WL, Goedee HS, Keijzer S, Keijser J, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Rispens T, Eftimov F; T2B! immunity against SARS-CoV-2 study group.
Wieske L, et al.
Ann Rheum Dis. 2023 Jun;82(6):883-885. doi: 10.1136/ard-2022-223464. Epub 2023 Jan 31.
Ann Rheum Dis. 2023.
PMID: 36720583
No abstract available.
Item in Clipboard
Cite
Cite